Condensed Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses (income):        
Research and development $ (1,785,645) $ 367,551 $ 5,815,580 $ 2,832,787
General and administrative 1,565,992 1,973,256 9,865,455 6,115,088
Total operating expenses (income) (219,653) 2,340,807 15,681,035 8,947,875
Income (loss) from operations 219,653 (2,340,807) (15,681,035) (8,947,875)
Other income (expense):        
Interest income 42,431 0 127,560 0
Interest expense (1,038,014) (110,508) (5,593,751) (281,638)
Total other expense, net (995,583) (110,508) (5,466,191) (281,638)
Loss before income taxes (775,930) (2,451,315) (21,147,226) (9,229,513)
Benefit from (provision for) income taxes 0 0 0 0
Net loss $ (775,930) $ (2,451,315) $ (21,147,226) $ (9,229,513)
Net loss per common share, basic and diluted [1] $ (0.03) $ (0.08) $ (0.87) $ (0.29)
Weighted-average common shares, basic and diluted [1] 25,818,495 31,545,000 24,269,266 31,545,000
[1] * Common shares adjusted for the exchange ratio from the reverse recapitalization